Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
How has the wearable injectors market grown in recent years?
The size of the wearable injectors market has significantly expanded in the past few years. There’s a forecasted increase from $8.84 billion in 2024 to a substantial $9.91 billion in 2025, with a compound annual growth rate (CAGR) of 12.1%. The historic growth has been fuelled by factors such as the management of chronic diseases, convenience for patients, technological progress, and the aging population.
How is the wearable injectors market size expected to evolve during the forecast period?
In the ensuing years, the market size for wearable injectors is anticipated to expand swiftly, reaching $17.45 billion in 2029 with a compound annual growth rate (CAGR) of 15.2%. This projected expansion in the forecast period can be ascribed to factors such as personalized medicine, remote patient tracking, drug enhancement, and chronic ailment management. The forecast period is also expected to be marked by key trends such as biologics and large molecules, dual-chamber wearables, connected and intelligent devices, and patch pump technology.
Get your wearable injectors market report here!
https://www.thebusinessresearchcompany.com/sample.aspx?id=3308&type=smp
Which key drivers are propelling the wearable injectors market’s growth?
Chronic conditions such as diabetes, cardiovascular diseases, and cancers growing prevalence has significantly influenced the amplification of the wearable injectors market. As an illustration, a report in April 2023 by the British Diabetic Association, a charity for those coping with diabetes in the UK, highlighted that there are around 4.3 million people presently diagnosed with diabetes in the country. Among these individuals, nearly 90% are identified with type 2 diabetes, nearly 8% with type 1 diabetes, and the remaining 2% have other forms of diabetes. This upsurge in the population of diabetic and chronic disease patients has led to an increased necessity for disease treatment, therefore propelling the wearable injectors market’s expansion.
What are the market segments in the wearable injectors industry?
The wearable injectors market covered in this report is segmented –
1) By Type: On-Body Injectors, Off-Body Injectors
2) By End-User: Hospitals, Clinics, Homecare setting
3) By Application: Immuno-Oncology, Diabetes, Cardiovascular Diseases, Other Applications
Subsegments:
1) By On-Body Injectors: Patch-Based Injectors, Adhesive-Based Injectors, Needle-Based Injectors, Needle-Free Injectors
2) By Off-Body Injectors: Belt-Based Injectors, Handheld Injectors, Clip-Based Injectors
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3308&type=smp
Which leading companies are shaping the growth of the wearable injectors market?
Major companies operating in the wearable injectors market include Amgen Inc., Becton Dickinson and Company (BD), Enable Injections LLC, Insulet Corporation, Ypsomed Holding AG, Medtronic MiniMed Inc., Tandem Diabetes Care Inc., Valeritas Inc., West Pharmaceutical Services Inc., Sensile Medical AG, Gerresheimer AG, Dexcom Inc., Consort Medical plc, United Therapeutics Corporation, Bühler Motor GmbH, Debiotech SA, Cellnovo Group, EoFlow Co. Ltd., CeQur SA, Haselmeier AG, Johnson & Johnson, kaleo Inc., Mylan N.V., Nemera Development S.A., F. Hoffmann-La Roche Ltd, Zosano Pharma Corporation
What key trends are currently impacting the wearable injectors market’s development?
Several firms operating in the wearable injectors manufacturing sector are concentrating their efforts on innovating products such as on-body injectors (OBI), with the aim to boost patient comfort, enhance adherence to recommended treatments, and meet the increasing demand for self-administration of biologic medicines. An On-Body Injector (OBI) is a wearable medication deliverance tool designed to give medications subcutaneously over a certain time frame, providing convenience for patients who require either large-volume injections or dosages with specific timing. For example, Coherus BioSciences Inc., a biotechnology firm based in the US, introduced UDENYCA in February 2024. UDENYCA, an advanced medicine delivery tool, is built on the LTS Sorrel wearable platform and is specifically intended for administering pegfilgrastim-cbqv, a biosimilar pegfilgrastim. This drug is administered the day after a chemotherapy treatment to reduce the chances of febrile neutropenia, a condition marked by fever and low white blood cell count due to infections. The OBI delivers precise doses and offers convenience for patients by permitting at-home administration, thus eliminating the requirement for further clinic visits.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3308
Which geographic areas are influencing the growth of the wearable injectors market?
North America was the largest region in the wearable injectors market in 2023. Western Europe was the second-largest region in the wearable injectors market analysis. The regions covered in the wearable injectors market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Browse Through More Similar Reports By The Business Research Company:
Implantable Drug Delivery Devices Global Market Report 2024
Cardiac Assist Devices And Equipment Global Market Report 2024
Pain Management Devices And Therapies Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
